News
Repealing sore loser laws could give voters more choices in November and reduce polarization, as it allows candidates who ...
PepsiCo. has retained a veteran competition lobbyist as the food and beverage giant works to refute allegations that it ...
Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...
Eli Roth‘s The Horror Section has acquired “Jimmy and Stiggs,” marking the horror company’s first major deal since launching earlier this month, Variety can exclusively report. Directed ...
Reserve your spot now. Eli Lilly And Co LLY, on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the ...
Public Affairs Analyst, Agada Theophilus, has described the member representing Egbeda/Ona Ara Federal Constituency in the House of Representatives, Akin Alabi, as an epitome of democracy.
Eli Soyud played inspired volleyball after erupting for a career-high game to help Akari eke out a 20-25, 25-19, 25-23, 22-25, 16-14, in the PVL All-Filipino Conference semifinals.
Global pharmaceutical giant Eli Lilly is expanding its footprint in India with a new technology center in Hyderabad as part of its broader strategy to enhance global research and development ...
Eli Lilly’s global CEO David Ricks has highlighted the significant costs of bringing new drugs to market, revealing that the average cost of developing a single drug is around $4 billion—even before ...
Mumbai | New Delhi: Pharma major Eli Lilly is open to partnerships with Indian companies to sell its blockbuster anti-diabetes and weight loss drug Mounjaro (tirzepatide), global CEO David Ricks told ...
In the latest trading session, Eli Lilly (LLY) closed at $852.35, marking a -1.45% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.16%. On the other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results